The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse X-TEND Seroquel SR Monotherapy in Maintenance of Bipolar
- collapse Seroquel acute manic
- collapse An 8-week International, Multicentre, Double-blind, Randomised, Parallel-group, Placebo-controlled, Phase III Study of the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) Sustained-release administered once daily as Monotherapy in the treatment of Adult Patients with Acute Bipolar Depression
- collapse A Multi-center, Randomized, Placebo-Controlled, Parallel-Group, Double-Blind, Phase III Study to Compare the Efficacy and Safety of Quetiapine Fumarate (SEROQUEL) versus Placebo as Adjunct Therapy with Mood Stabilizers (Lithium or Divalproex) for the Treatment of Alcohol Dependence in Patients with Bipolar I Disorder
- collapse An Open-Label Study to Assess the Steady-State Pharmacokinetics, Safety and Tolerability of Seroquel XR (Quetiapine Fumarate) Extended-ReleaseTablets and Seroquel IR (Quetiapine Fumarate) Immediate ReleaseTablets in Children and Adolescents with selected Psychotic and Mood Disorders
- collapse An open-label, non-comparative, single centre, phase II exploratory study to assess the efficacy of a flexible dose of oral Quetiapine Fumarate tablets (300-800 mg) in the treatment of Borderline Personalisty Disorder in adult patients receiving treatment for 12 weeks.
- collapse ATTITUDE
- collapse Efficacy of Quetiapine in Generalised Social Anxiety Disorder - a double-blind, placebo-controlled study
- collapse Open lable, pilot study of a fast titration of quetiapine switched by an initial treatment with injective haloperidol in acute manic in-patients
- collapse A randomized, parallel group, open Trial Examining the Safety, Efficacy adn Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine fumarate compared to standard titration, 400mg/day by day 4, in the treatment of Bipolar 1 Manic Episode.
